基因组测序市场：现状分析与预测（2022-2028）

基因组测序的市场规模预计将在 2022 年至 2028 年间以约 13% 的复合年增长率增长。 DNA测序技术已经从第一代发展到第三代。 由于其特性，DNA 测序系统得到了普及，并有望对 DNA 测序市场产生积极影响。 由于对基于 NGS 的诊断的重视以及全球癌症发病率的迅速增加，对基因组测序的需求不断增加。

本报告调查了全球基因组测序市场，提供了市场概况、产品趋势、技术、应用、最终用户、地区以及进入市场的公司概况。

内容

第一章市场介绍

第 2 章基因组测序市场研究方法

第三章市场总结

第 4 章执行摘要

第 5 章 COVID-19 的影响

第 6 章全球基因组测序市场收入，2020-2028

第 7 章产品市场洞察

• 消耗品
• 设备
• 服务

第 8 章技术市场洞察

• 桑格测序
• 下一代测序
• 聚合□链反应
• 微阵列
• 其他

第 9 章应用市场洞察

• 肿瘤学
• 生殖医学
• 复杂疾病研究
• 药物发现和开发
• 精准医学
• 农业和动物研究
• 其他

第 10 章最终用户的市场洞察

• 学术研究中心
• 製药和生物技术公司
• 消费者基因组服务提供商
• 政府机构
• 其他

第 11 章按地区划分的市场洞察

• 北美基因组测序市场
• 欧洲基因组测序市场
• 亚太基因组测序市场
• 世界其他地区的基因组测序市场

第 12 章基因组测序市场动态

• 市场驱动力
• 市场挑战
• 影响分析

第 13 章基因组测序的市场机会

第 14 章基因组测序市场趋势和洞察

第15章需求侧与供给侧分析

第 16 章价值链分析

第十七章价格分析

第 18 章战略洞察

第 19 章衝突场景

第20章公司简介

• Agilent Technologies Inc
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Qiagen NV
• BGI Genomics Co Ltd
• Oxford Nanopore Technologies PLC
• Macrogen Inc
• PerkinElmer, Inc.
• Pacific Biosciences of California Inc
• Bio-Rad Laboratories, Inc.

第21章 免责事项

The genome sequencing market is expected to register a CAGR of approx. 13% over the period of 2022-2028. The process of mapping and sequencing a person's individual DNA is known as genome sequencing. The term "genome" refers to the complete blueprint of a person's human body. A person's genes, which are a bundle of DNA, can cause a disease or increase the likelihood of disease. Genome sequencing helps to identify any significant differences in the genes, which can increase the likelihood of disease. DNA sequencing is inexpensive, has high accuracy and speed, and can produce results from small samples. DNA sequencing technologies have advanced from the first to the third generation. Because of their features, DNA sequencing systems have gained traction, which may have a positive impact on the DNA sequencing market. The growing demand for genome sequencing can be attributed to the growing emphasis on NGS-based diagnostics and surging incidences of cancer across the globe. For instance, the number of cancer cases in the US will increase 49% each year, from 1,534,500 in 2015 to 2,286,300 in 2050, with the largest percentage increase among adults aged ≥75 years, as per the predictions by CDC. Owing to the glaring statistics the increase in cancer prevalence has created a buzz among biotechnology and pharmaceutical companies for investing in the development of effective and reliable diagnostic tools which boosts the demand for genome sequencing across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the genome sequencing market is anticipated to grow on account of the rapid advancements in sequencing technology and bioinformatics. In addition, changes in lifestyle and various health-related issues drive market growth. However, some of the restraints in the market including the Lack of trained professionals and the high cost of establishing and maintaining a sequencing facility are impeding the growth of this market all over the world.

Agilent Technologies Inc; Thermo Fisher Scientific, Inc.; Illumina, Inc.; Qiagen NV; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; Macrogen Inc; PerkinElmer, Inc.; Pacific Biosciences of California Inc; Bio-Rad Laboratories, Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, the consumables category led the market in 2020 with the highest market share"

Based on the product, the genome sequencing market is segmented into consumables, instruments, and services. The consumables segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. A larger share of the segment is attributed to the broad availability of reagents and kits to address all stages of library construction, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. The majority of these tools support low-input and formalin-fixed specimens and have streamlined and simplified workflows, ready-to-use components, and components.

"Amongst technology, the next-generation sequencing category led the market in 2020 with the highest market share"

Based on the technology, the market is fragmented into sanger sequencing, next-generation sequencing, polymerase chain reaction, microarrays, and others. The next-generation sequencing segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The rapid advancements in these technologies, combined with the decreasing cost of sequencing, have made genome sequencing faster, more affordable, and more accurate. Additionally, the use of NGS technology for routine clinical diagnostic tests is growing, especially in light of the COVID-19 infection pandemic, which benefits the segment's revenue share.

"Amongst applications, the oncology category is expected to hold considerable market share during the forecast period"

Based on the application, the market is fragmented into oncology, reproductive health, complex disease research, drug discovery and development, precision medicine, agriculture and animal research, and others. The oncology segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The technology has enormous potential for clinical research as well as the creation of cancer diagnostics and therapeutics. Recent advancements in NGS technology have shown its potential as a high-throughput, low-cost method for identifying and characterizing clinically useful genetic variants across a wide range of genes quickly and in a single test.

"Amongst end-user, the academic & research centers category is expected to witness considerable CAGR during the forecast period"

Based on the end-user, the market is fragmented into academic & research centers, pharmaceutical and biotechnology companies, consumer genomic service providers, government institutes, and others. The academic & research centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Sanger technology and NGS are widely used in academic and institutional research projects because of their widespread acceptance. Additionally, an increase in funding and investment initiatives boosts the demand for DNA sequencing products in these organizations, leading to a higher revenue share.

"North America to witness significant growth during the forecast period"

For a better understanding of the market adoption of the genome sequencing, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the genome sequencing industry owing to the continuous technological developments by key players, high investment in R&D, availability of technologically advanced healthcare infrastructure, rising need for personalized medicine and the presence of several government initiatives in the U.S. and Canada supports research in drug development and treatment of cancer.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global genome sequencing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Genome Sequencing Market

2 2.2. Research Methodology of the Genome Sequencing Market

• 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE GENOME SEQUENCING MARKET

6 GLOBAL GENOME SEQUENCING MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Consumables
• 7.2. Instruments
• 7.3. Services

8 MARKET INSIGHTS BY TECHNOLOGY

• 8.1. Sanger Sequencing
• 8.2. Next-Generation Sequencing
• 8.3. Polymerase Chain Reaction
• 8.4. Microarrays
• 8.5. Others

9 MARKET INSIGHTS BY APPLICATION

• 9.1. Oncology
• 9.2. Reproductive Health
• 9.3. Complex Disease Research
• 9.4. Drug Discovery and Development
• 9.5. Precision Medicine
• 9.6. Agriculture and Animal Research
• 9.7. Others

10 MARKET INSIGHTS BY END-USERS

• 10.1. Academic & Research Centers
• 10.2. Pharmaceutical and Biotechnology Companies
• 10.3. Consumer Genomic Service Providers
• 10.4. Government Institutes
• 10.5. Others

11 MARKET INSIGHTS BY REGION

• 11.1 NORTH AMERICA GENOME SEQUENCING MARKET
  • 11.1.1 U.S.
  • 11.1.2 Canada
  • 11.1.3 Rest of North America
• 11.2 EUROPE GENOME SEQUENCING MARKET
  • 11.2.1 Germany
  • 11.2.2 U.K.
  • 11.2.3 France
  • 11.2.4 Spain
  • 11.2.5 Italy
  • 11.2.6 Rest of Europe
• 11.3 ASIA PACIFIC GENOME SEQUENCING MARKET
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 Australia
  • 11.3.5 Rest of Asia Pacific
• 11.4 REST OF THE WORLD GENOME SEQUENCING MARKET

12 GENOME SEQUENCING MARKET DYNAMICS

• 12.1 Market Drivers
• 12.2 Market Challenges
• 12.3 Impact Analysis

13 GENOME SEQUENCING MARKET OPPORTUNITIES

14 GENOME SEQUENCING MARKET TRENDS & INSIGHTS

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1 Demand Side Analysis
• 15.2 Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

• 19.1. Competitive Landscape
  • 19.1.1 Porter's Five forces analysis

20 COMPANY PROFILED

• 20.1. Agilent Technologies Inc
• 20.2. Thermo Fisher Scientific, Inc.
• 20.3. Illumina, Inc.
• 20.4. Qiagen NV
• 20.5. BGI Genomics Co Ltd
• 20.6. Oxford Nanopore Technologies PLC
• 20.7. Macrogen Inc
• 20.8. PerkinElmer, Inc.
• 20.9. Pacific Biosciences of California Inc
• 20.10. Bio-Rad Laboratories, Inc.

21 DISCLAIMER